Version 5.4
Bos taurus Protein: SLC18A2
Summary
InnateDB Protein IDBP-692483.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC18A2
Protein Name synaptic vesicular amine transporter
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000006221
InnateDB Gene IDBG-640240 (SLC18A2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0015238 drug transmembrane transporter activity
Biological Process
GO:0001975 response to amphetamine
GO:0006855 drug transmembrane transport
GO:0007626 locomotory behavior
GO:0009636 response to toxic substance
GO:0009791 post-embryonic development
GO:0015893 drug transport
GO:0016265 death
GO:0055085 transmembrane transport
Cellular Component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR004734 Multidrug resistance protein
IPR011701 Major facilitator superfamily
IPR020846 Major facilitator superfamily domain
PFAM PF07690
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL B0JYP2
UniProt Splice Variant
Entrez Gene 282471
UniGene Bt.5030
RefSeq NP_777078
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC151472 DAAA02059347 DAAA02059348
GenPept AAI51473

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca